ACTA LINGUIST HUNGAR 润色咨询

Acta Linguistica Hungarica

出版年份：暂无数据 年文章数：19 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1111940, encodeId=773011119400f, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111939, encodeId=bab911119396b, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083484, encodeId=dad610834842a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：药学相关<br>经验分享：等分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=070d2007575, createdName=sjb, createdTime=Thu Dec 23 10:19:26 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-28 msSSSSSD

    SCI文章有没有写作模板？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1111940, encodeId=773011119400f, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111939, encodeId=bab911119396b, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083484, encodeId=dad610834842a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：药学相关<br>经验分享：等分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=070d2007575, createdName=sjb, createdTime=Thu Dec 23 10:19:26 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1111940, encodeId=773011119400f, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111939, encodeId=bab911119396b, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083484, encodeId=dad610834842a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：药学相关<br>经验分享：等分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=070d2007575, createdName=sjb, createdTime=Thu Dec 23 10:19:26 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-23 sjb

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向：药学相关
    经验分享：等分享

    0

共5条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分